Hara Ryujiro

Research theme for competitive and other funds (2)：

2021 - 2023 移植後特発性肺炎症候群の解明:アンジオテンシン2が肺胞マクロファージを活性化する
2019 - 2021 Elucidation of post-transplant idiopathic pneumonia syndrome: is angiotensinogen a predictor and prophylaxis?

Papers (18)：

Ryujiro Hara, Machida S, Hashimoto N, Ogiya D, Kawai H, Kawakami S, Shiraiwa S, Onizuka M, Ogawa Y, Kawada H, et al. Impact of previous anthracycline therapy in patients with acute myeloid leukemia receiving venetoclax. International journal of hematology. 2023
Makoto Onizuka, Eri Kikkawa, Shinichiro Machida, Masako Toyosaki, Rikio Suzuki, Daisuke Ogiya, Yasuyuki Aoyama, Jun Amaki, Kaito Harada, Ryujiro Hara, et al. Association of CDKN2A/2B deletion with relapse after hematopoietic stem cell transplantation for acute lymphoblastic leukemia. Blood cell therapy. 2023. 6. 3. 80-86
Yo Kawarada, Ryujiro Hara, Toshihiko Kitahara, Hiroki Numata, Shigeki Watanabe, Masatoshi Yamada, Kiyoshi Ando. Aplastic Anemia with Epstein-Barr Virus Reactivation after Anti-thymocyte Globulin Therapy. Internal Medicine. 2023
Ryujiro Hara, Toshihiko Kitahara, Hiroki Numata, Masako Toyosaki, Shigeki Watanabe, Eri Kikkawa, Yoshiaki Ogawa, Hiroshi Kawada, Kiyoshi Ando. Fetal hemoglobin level predicts lower-risk myelodysplastic syndrome. International Journal of Hematology. 2022
Sawako Shiraiwa, Kaito Harada, Makoto Onizuka, Shohei Kawakami, Ryujiro Hara, Yasuyuki Aoyama, Jun Amaki, Daisuke Ogiya, Rikio Suzuki, Masako Toyosaki, et al. Risk factors for lower respiratory tract disease and outcomes in allogeneic hematopoietic stem cell transplantation recipients with influenza virus infection. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2022. 28. 9. 1279-1285

ｍore...

Professional career (1)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page